Latest Breaking News On - Caligan partners - Page 3 : comparemela.com

Liquidia Stock Gains Edge In PAH Market Following Key Legal Victory (NASDAQ:LQDA)

Liquidia Stock Gains Edge In PAH Market Following Key Legal Victory (NASDAQ:LQDA)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

United statesUnited states courtFinancial healthUnited therapeuticLung leap over unitedPatent trialAppeal boardSeeking alphaCaligan partnersUnited therapeutics

MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution -December 11, 2023 at 10:03 am EST

EQS Voting Rights Announcement: MorphoSys AG MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of.

David johnsonNotification of major holdingsDistribution servicesCaligan partnersRights announcementVoting rights announcementEntity identifierRegulatory announcementsCorporate news

Anika Therapeutics, Inc (NASDAQ:ANIK) is favoured by institutional owners who hold 66% of the company

Key Insights Institutions' substantial holdings in Anika Therapeutics implies that they have significant influence over.

Cheryl blanchardAnika therapeutics incTrigran investments incBlackrock incAnika therapeuticsAnika therapeuticTrigran investmentsCaligan partnersNstitutional ownershipInstitutional investorsAnika therapeuticsNsider ownership

Evolus (NASDAQ:EOLS) Stock Price Down 4 2%

Evolus (NASDAQ:EOLS) Stock Price Down 4 2%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesSandra beaverVikram malikStonepine capital managementBlackrock incGreat point partnersSecurities exchange commissionEvolus incVanguard group incNeedham companyGet free reportDirector vikram malikExchange commissionCapital managementPoint partnersCaligan partners

Caligan Partners LP Reduces Stake in Alimera Sciences Inc

Caligan Partners LP (Trades, Portfolio), a New York-based investment firm, recently made a significant transaction in its portfolio. The firm reduced its stake in Alimera Sciences Inc, a commercial-stage pharmaceutical company. On September 14, 2023, Caligan Partners LP (Trades, Portfolio) reduced its holdings in Alimera Sciences Inc by 800,000 shares, representing a 4.54% change in the firm's portfolio.

Alimera sciences incAnalysis of alimera sciences inc industry positionOverview of alimera sciences incAnalysis of alimera sciences inc stock performanceEvaluation of alimera sciences inc financial healthAlimera sciencesSciences incInitial public offeringBalance sheet rankProfitability rankGrowth rankPiotroskif scoreAltmanz scoreDrug manufacturersCaligan partnersCaligan partners lp